Journals / Türk Kardiyoloji Derneği Arşivi / 2013 / Cilt: 41 - Sayı: 7

Miyokart enfarktüsü sonrası geç dönemde plazma matriks metalloproteinaz-8 seviyelerinin sol ventrikül hacimleri ve ejeksiyon fraksiyonu ile ilişkisi

Relation of plasma matrix metalloproteinase-8 levels late after myocardial infarction with left ventricular volumes and ejection fraction

Pages
617–624
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The MMP-8 levels were significantly higher in post- MI patients [median 3.88 ng/ml, interquartile range (1.88- 6.43) vs. 0.67 ng/ml (0.34-2.47); p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Enhanced matrix metalloproteinase-8 (MMP-8) activity in the early post-myocardial infarction (MI) period has been related to early remodeling.
📊
Key Findings & Data:However, it has been dem- onstrated that plasma MMP-8 level has a biphasic profile, and the relation between the late plasma levels and remodeling is unclear.
💡
Conclusion & Impact:Results: The MMP-8 levels were significantly higher in post- MI patients [median 3.88 ng/ml, interquartile range (1.88- 6.43) vs. 0.67 ng/ml (0.34-2.47); p
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Enhanced matrix metalloproteinase-8 (MMP-8) activity in the early post-myocardial infarction (MI) period has been related to early remodeling. However, it has been dem- onstrated that plasma MMP-8 level has a biphasic profile, and the relation between the late plasma levels and remodeling is unclear. We evaluated the plasma MMP-8 levels and its cor- relates 20±3 months after acute MI. Study design: 58 post-MI patients and 26 control subjects underwent quantitative single-photon emission computed tomography (SPECT) and echocardiography. The plasma MMP-8 levels were measured and its correlates were inves- tigated. Results: The MMP-8 levels were significantly higher in post- MI patients [median 3.88 ng/ml, interquartile range (1.88- 6.43) vs. 0.67 ng/ml (0.34-2.47); p

Özet

Amaç: Miyokart enfarktüsü (ME) sonrası erken dönemde artmış matriks metalloproteinaz-8 (MMP-8) aktivitesinin erken yeniden şekillenme ile ilişkisi olduğu bilinmektedir. Ancak MMP-8in bifazik bir profile sahip olduğu gösterilmiştir ve geç dönem plazma seviyeleri ile yeniden şekillenme arasındaki ilişki net değildir. Çalışmamızda MEnin 20±3 ay sonrasında plazma MMP-8 seviyelerini ve klinik parametrelerle olan ilişkisini inceledik.Çalışma planı: Miyokart enfaktüsü geçirmiş 58 hasta ve 26 bireylik kontrol grubuna kantitatif tek-foton emisyon bilgisayarlı tomografi (SPECT) ve ekokardiyografi yapıldı. Plazma MMP-8 seviyeleri ölçüldü ve korelasyonları incelendi.Bulgular: Plazma MMP-8 seviyeleri ME geçirmişlerde anlamlı olarak daha yüksek idi [medyan 3.88 ng/ml, çeyreklerarası aralık (1.88-6.43) ve 0.67 ng/ml (0.34-2.47); p

🔖

Cite This Article

KIZILIRMAK, F., ERKOL, A., KILICGEDİK, A., PALA, S., ODUNCU, V., KIRMA, C., GÜLER, A., KARABAY, C. Y. (2022). Miyokart enfarktüsü sonrası geç dönemde plazma matriks metalloproteinaz-8 seviyelerinin sol ventrikül hacimleri ve ejeksiyon fraksiyonu ile ilişkisi. Türk Kardiyoloji Derneği Arşivi, Cilt: 41 - Sayı: 7, 617–624. https://ajindex.com/articles/632876

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000;35:569-82
  2. Wilson EM, Gunasinghe HR, Coker ML, Sprunger P, Lee- Jackson D, Bozkurt B, et al. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail 2002;8:390-8
  3. Chapman RE, Spinale FG. Extracellular protease activation and unraveling of the myocardial interstitium: critical steps toward clinical applications. Am J Physiol Heart Circ Physiol 2004;286:H1-H10
  4. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 2002;90:520-30
  5. Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, Samani NJ, et al. Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study. Eur Heart J 2007;28:711-8. 6. van den Borne SW, Cleutjens JP, Hanemaaijer R, Creemers EE, Smits JF, Daemen MJ, et al. Increased matrix metalloproteinase- 8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol 2009;18:37-43
  6. Webb CS, Bonnema DD, Ahmed SH, Leonardi AH, McClure CD, Clark LL, et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction: relation to left ventricular remodeling. Circulation 2006;114:1020-7
  7. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004;17:1086-119
  8. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161-72
  9. Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res 2006;69:604-13
  10. Yan AT, Yan RT, Spinale FG, Afzal R, Gunasinghe HR, Arnold M, et al. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure. J Card Fail 2006;12:514-9
  11. Bradham WS, Gunasinghe H, Holder JR, Multani M, Killip D, Anderson M, et al. Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive car